Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel for Ovarian Cancer Prevention in High-Risk Women
NCT00445887Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Mar 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in ovarian carcinoma, sponsored by GOG Foundation. Started Mar 2008; status: completed.
02
Drugs
avatrombopag
03
Conditions
ovarian carcinoma
Beyond the preview
Go deeper on NCT00445887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445887.